The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

Recruiting now

Conditions studied: Pancreatic Cancer, Microbiome

In brief

This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.

Key facts

Study ID

NCT07250100

Run by

Herlev Hospital

People needed

300

Starts

2025-11-01

Expected to finish

2037-12-01

Last updated by the study team

2025-11-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure
• Age of 18 years or above
• Signed informed consent form

You may not qualify if…

• Contraindications for endoscopic or surgical procedure, such as uncorrected coagulopathy

Where it is running

• Herlev og Gentofte Hospital — Herlev, Capital Region, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.